Inhaled nitric oxide and the societal perspective [5] (multiple letters)

Pediatrics

Volumn 113, Issue 6 I, 2004, Pages 1849-1851

  Hansen, Thor Willy Ruud ^a   Field, David ^b   Normand, Charles ^c   Elbourne, Diana ^c   Angus, Derek C ^d   Clermont, Gilles ^d   Watson, R Scott ^d   Linde Zwirble, Walter T ^e  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e Health Process Management LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

COST EFFECTIVENESS ANALYSIS; DRUG COST; HEALTH CARE COST; HUMAN; INFANT; INFANT MORTALITY; LETTER; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEONATOLOGY; NEWBORN; PATENT; PREMATURITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SOCIETY;

ADMINISTRATION, INHALATION; CONFLICT OF INTEREST; COST-BENEFIT ANALYSIS; DRUG INDUSTRY; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; NITRIC OXIDE; PERSISTENT FETAL CIRCULATION SYNDROME; RESPIRATORY INSUFFICIENCY; UNITED STATES;

EID: 2542567314     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.113.6.1849     Document Type: Letter

References (0)